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Abstract
Background: Patients with stable coronary artery disease (CAD) have a worse quality of life (QoL) 
in comparison to patients without stable CAD. Standardized questionnaires are used in evaluation of 
QoL. Hybrid coronary revascularization (HCR) is a recently-introduced, minimally invasive option for 
patients requiring revascularization for coronary lesions. The aim of this study was to assess health-
related quality of life (HRQoL) in patients with multivessel CAD (MVCAD), according to the mode 
of revascularization: coronary artery bypass grafting (CABG) or HCR, using the generic SF-36 v.2  
questionnaire. 
Methods: From November 2009 to July 2012, 200 patients from POLMIDES study with diagnosed 
MVCAD and were referred for conventional CABG were randomized to HCR (n = 98) or CABG 
(n =102) groups in 1:1 ratio. HRQoL were measured at two time points: hospital admission and 
12-month follow up. The primary endpoint was the difference in HRQoL after the procedure.
Results: Both groups showed the same improvement of HRQoL: in HCR group: 13.5 (3.82–22.34) vs. 
CABG group: 10.48 (2.46–31.07); p = 0.76. 
Conclusions: HRQoL in patients after both modes of revascularization significantly improved after  
12 months in all domains. (Cardiol J 2018; 25, 5: 621–627)
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Introduction
Stable coronary artery disease (CAD) has 
a negative impact on physical and psychological 
functioning of patients. It has been proven that 
patients with stable CAD have a worse quality of 
life (QoL) in comparison to patients without stable 
CAD [1]. The holistic approach to patient health 
has lead to a dynamic growth of interest in research 
concerning QoL in cardiovascular diseases. From 
the 90s of the twentieth century health-relalet 
quality of life (HRQoL) has become an important 
health outcome indicator [2–4]. Standardized 
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There are two types of questionnaires: generic and 
disease-specific. One of the most widely used ge-
neric health status instruments to assess HRQoL 
is the Medical Outcomes Study Short Form (SF-36) 
questionnaire and it has been studied in many 
populations, also in patients with CAD and valvu-
lar heart disease [5–9]. Many studies have shown 
that coronary artery bypass grafting (CABG) is 
a favorable method of revascularization in patients 
with multivessel CAD (MVCAD). For patients 
with low SYNTAX score, percutaneous coronary 
intervention (PCI) is an acceptable revasculariza-
tion strategy, although at the price of significantly 
higher rates of repeat revascularization [10]. Hy-
brid coronary revascularization (HCR) is a recently 
introduced, minimally invasive option for patients 
requiring revascularization for coronary lesions. 
Even though CABG is still the gold standard treat-
ment for patients with MVCAD, HCR is also an ac-
cepted method of revascularization in this group of 
patients [11]. The POLMIDES study showed that 
HCR is feasible in selected patients with MVCAD 
referred for conventional CABG [12]. There are 
a few studies comparing QoL in patients with MV-
CAD treated with HCR and CABG. The aim of this 
study was to assess QoL in patients with MVCAD 
according to the mode of revascularization: CABG 
or HCR, using the generic SF-36 v.2 questionnaire. 
Methods
From November 2009 to July 2012, 200 pa-
tients from the POLMIDES study with diagnosed 
MVCAD and referred for conventional CABG were 
randomized to HCR (n = 98) or CABG (n =102) 
in a 1:1 ratio. Before randomization the local heart 
team checked all the inclusion/exclusion criteria 
and the eligibility to perform CABG and PCI in 
all study participants, described previously in the 
POLMIDES study design [13]. Figure 1 shows the 
study flow chart. Six patients crossed over from 
HCR group to CABG group. During the follow-up 
observation 5 patients died. Fifteen patients from 
the HCR group and 21 patients from CABG group 
were lost to follow-up because of the incomplete 
HRQoL questionnaire or disagreement to undergo 
control angiography to assess the patency of grafts 
and restenosis in revascularized segments. Com-
plete in-hospital and follow-up data were obtained 
from the target group: 159 (79.5%) patients: 75 
(76.5%) patients in HCR group and in 84 (82.4%) 
patients in CABG group. The primary endpoint was 
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Figure 1. Study flow chart; CABG — coronary artery bypass grafting; HCR — hybrid coronary revascularization.
the change in HRQoL after the procedure. QoL 
was assessed by using the Polish version of the 
Medical Outcomes Study 36  questionaire version 
2.0. A license for the use of SF-36 v.2 was obtained 
from OptumInsight Life Sciences, Inc., license 
number QM022262. The data from the HRQoL 
questionnaire were self-reported by the patients 
in the presence of the study psychologist. HRQoL 
was measured at two time points: hospital admis-
sion and at 12-months follow up. Subsequently the 
difference in HRQoL at this two time points was 
assessed. This questionnaire consists of 36 items or 
questions grouped into eight health-related aspects 
of the patient’s life: Physical Functioning (PF), Role 
Physical (RF), Bodily Pain (BP), General Health 
(GH) Perceptions, Vitality (VT), Social Function-
ing (SF), Role–Emotional (RE) and Mental Health 
(MH). In addition, two summary scores are calcu-
lated using these eight scales: a physical component 
summary (PCS) consisting of PF+RF+BT+GH and 
a mental component summary (MCS) consisting of 
VT+SF+RE+MH. Each of the subscales is scored 
on a scale of 0–100, with higher scores indicating 
better outcomes. The PCS and MCS use norm-
based scoring and have a mean of 50 and a standard 
deviation of 10. Also, there is one additional question 
comparing a patients’ current health with that of the 
previous year. The demographic profile investigation 
questionnaire included questions on educational 
attainment, marital status, employment status and 
place of residence. Occurrence of major cardiac and 
cerebrovascular adverse events such as myocardial 
infarction, stroke, major bleeding and target vessel 
revascularization through the 12-month period after 
randomization was also assessed. The definition of 
stroke, myocardial infarction, major bleeding, repeat 
revascularization and target vessel revascularization 
as described previously [13]. Diabetic patients were 
either treated with diet only, oral drugs or insulin 
injections. Dyslipidemia was defined as raised lev-
els or cholesterol or triglycerides diagnosed before 
admission to hospital or during index hospitalization 
and was treated according to current guidelines. 
Obesity was diagnosed with body mass index over 
30 kg/m2. 
The study conforms to the Declaration of 
Helsinki. The protocol was approved by the Ethics 
Committee of the Medical University of Silesia and 
all participants gave written, informed consent.
Statistical analysis
Continuous variables were presented as the 
mean ± standard deviation or median and inter-
quartile range.
Categorical variables were presented as fre-
quencies and percentages. The normality as-
sumption for continuous variables was checked by 
means of Shapiro-Wilk test. To test for differences 
between the CABG and HCR groups, the c2 test and 
Fisher’s exact test were used for categorical vari-
ables, and the Student t-test or Wilcoxon-Mann-
Whitney test were used for continuous variables 
where appropriate. 
Moreover, the difference in HRQoL between 
hospital admission and 12-months follow-up (for 
all domains) was categorized as an improvement 
in QoL when the difference was greater than 0 and 
a lack of improvement was observed otherwise. 
Next, such categorized variables were used in the 
multivariable logistic regression to evaluate the 
association between QoL improvement and the 
revascularization method adjusted for confounders. 
The stepwise selection method was used to build 
logistic regression models. A two-sided p value 
< 0.05 was considered statistically significant. 
Statistical tests were performed with SAS version 
9.4 software.
Results
Baseline characteristics are shown in Table 1. 
The vast majority in both groups were men of good 
global left ventricular systolic function (LVEF 
50%). Body mass index values in both groups were 
similar. About 30% of study subjects had diabetes, 
while more than 80% had hypertension. A mean 
SYNTAX score was 23.0 in the CABG group and 
23.5 in the HCR group (p = 0.76). Clinical events 
which occurred during hospital stay and follow-up 
are presented in Table 2. No patients died during 
in-hospital stay. There were no significant differ-
ences in in-hospital outcomes and during follow-up. 
The length of hospitalization was similar in both 
groups: 7.0 days (7.0–9.0) vs. 7.0 days (6.0–9.0), 
p = 0.17. For both treatment groups, assessment 
at 1 year revealed an improvement in QoL com-
pared with the preintervention assessment in all 
8 domains (Fig. 2). There was a substantial dif-
ference in HRQoL between treatment groups on 
admission. The general QoL of patients randomized 
to HCR was significantly higher at baseline and in 
12 month follow-up than in patients randomized to 
CABG (59.2 vs. 51.3; p < 0.005) and (73.7 vs. 65.6; 
p < 0.005). Both groups had the same QoL improve- 
ment: in HCR group: 13.5 (3.82–22.34) vs. CABG 
group: 10.48 (2.46–31.07); p = 0.76. Independent 
predictors of improvement in 6 out of 8 domains are 
presented in Figure 3. There were no independent 
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Table 2. Clinical endpoints occurring in the  
hospital or after discharge.
CABG HCR P
In-hospital outcomes
Stroke 0 (0%) 0 (0%) 1
Perioperative MI 4 (4.8%) 3 (4%) 0.87
Major bleeding 3 (3.6%) 1 (1.3%) 0.62
Renal failure 0 (0%) 0 (0%) 1
Blood transfusion 20 (24%) 11 (15%) 0.15
Death 0 (0%) 0 (0%) 1
12 month follow up outcomes
Stroke 0 0 1
MI 0 1 (1.3%) 0.47
TVR 0 2 (2.7%) 0.22
Repeat hospitalization 5 (6%) 6 (8%) 0.76
CABG — coronary artery bypass grafting; HCR — hybrid coronary 
revascularization; MI — myocardial infarction; TVR — target vessel 
revascularization
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Table 1. Baseline clinical characteristics.
CABG HCR P
Age at randomization [years] 63.5 (59.0–71.0) 64.0 (57.0–69.0) 0.43
Male 66 (78.6%) 58 (77.3%) 0.85
Body mass index [kg/m2] 28.9 ± 4.02 28.01 ± 3.23 0.13
Hypertension 68 (81%) 67 (89.3%) 0.14
Diabetes 25 (29,8%) 20 (26.7%) 0.67
Dyslipiemia 49 (58.3%) 41 (54.7%) 0.64
Obesity 37 (44%) 26 (34.7%) 0.23
Current smoker 32 (38.1%) 23 (30.7%) 0.33
Atrial fibrillation 5 (6%) 4 (5.3%) 0.87
Ejection fraction [%] 50 (45–55) 50 (48–54) 0.66
Previous MI 49 (58.3%) 37 (49.3%) 0.26
Previous PCI 35 (41.7%) 29 (38.7%) 0.7
Previous stroke 4 (4.8%) 3 (4%) 0.82
Previous TIA 2 (2.4%) 0 0.18
Carotid artery disease 10 (11.9%) 8 (10.7%) 0.81
Stable angina 69 (82.1%) 63 (84%) 0.76
Unstable angina 15 (17.9%) 12 (16%) 0.76
Logistic EuroSCORE [points] 3 (2–5) 3 (1–5) 0.15
SYNTAX score 23.0 (19.3–26.0) 23.5 (18.0–26.5) 0.76
2 vessel CAD 45 (53.6%) 35 (46.7%) 0.39
3 vessel CAD 39 (46.4%) 40 (53.3%)
Categorical variables were expressed as frequencies (percentages), continuous variables were expressed as mean ± standard deviation for 
normally distributed data and median (1st and 3rd quartile) for non-normally distributed data. CABG — coronary artery bypass grafting;  
CAD — coronary artery disease; HCR — hybrid coronary revascularization; LIMA — left internal mammary artery; MI — myocardial infarction; 
MIDCAB — minimally invasive coronary artery bypass; PCI — percutaneous coronary intervention; TIA — transient ischemic attack
Table 3. Health-related quality of life improvement 
rates in various populations.
CABG HCR P
Degree of education
Lower education 83.7% 90.6% 0.38
Higher education 83.3% 85.7% 0.79
Marital status
Relationship 82% 88.7% 0.32
Alone 91% 85% 0.64
Employment
Employed 83.3% 80% 0.82
Unemployed 83.3% 90.4% 0.27
Place of living
City 83.1% 86.7% 0.61
Rural 85.7% 91% 0.63
CABG — coronary artery bypass grafting; HCR — hybrid coronary 
revascularization
predictors of improvement in domain RE, VT and 
PCS. Observation revealed that obesity worsened 
QoL in PF and MCS domain, female gender im-
proved QoL in BP domain. In addition, analysis 
shows whether the degree of education (lower 
vs. higher), marital status (relationship vs. alone) 
employment (employed vs. unemployed) and place 
of living (city vs. village) had an influence on im-
provement in quality of life in both groups (HCR 
and CABG). Depending on these factors, patients 
in both groups did not differ significantly (Table 3). 
Over 80% of all patients regardless of these factors 
felt improvement in HRQoL after the procedure. 
Discussion
More and more frequently, physicians not 
only evaluate patient biological conditions, but 
also consider the impact of disease and treatment 
methods on patient functioning in everyday life. 
In recent years there has been an increasing use 
of instruments measuring QoL, particularly the 
HRQoL. The Medical Outcomes Study Short Form 
version 2 (SF-36 v.2) is considered to be a reliable, 
valid, concise generic measure of state of health 
that is widely used in heart disease [14]. Accord-
ing to Dempster and Donnelly SF-36 is the most 
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Figure 3. Independent predictors of improvement of quality of life — results of the logistic regression analysis; BP — 
bodily pain; CCS — Canadian Cardiovascular Society Class; CI — confidence interval; EF — ejection fraction on ad-
mission; EF — ejection fraction; GH — General Health; MCS — Mental Component Summary; MH — Mental Health; 
NYHA — New York Heart Association; OR — odds ratio; PF — Physical Functioning; PVD — Peripheral Vascular 
Disease; RP — Role Physical; SF — Social Functioning; SF-36 — Short Form 36 Health Survey. 
Figure 2. Improvement in health-related quality of life; 
CABG — coronary artery bypass grafting; HCR — hybrid 
coronary revascularization.
appropriate generic instrument to assess HRQoL 
in patient with ischemic heart disease [15]. They 
compared the validity, reliability, and sensitivity 
of the SF-36 with other generic questionnaires 
such as the Nottingham Health Profile and the 
Sickness Impact Profile for patients with CAD. 
Numerous studies including RITA and CABRI 
trial have examined HRQoL after PCI or CABG 
and demonstrated significant improvements in 
HRQoL for patients undergoing percutaneous or 
surgical revascularization which compare baseline 
and also compare with medical therapy [16, 17]. 
This became the basis for research of QoL. Ange-
lini et al. [18] reported the first HCR procedure 
in 1996. The concept was based on performing 
a minimally invasive thoracotomy LIMA-LAD 
anastomosis and balloon angioplasty of non-LAD 
vessels. Hybrid coronary revascularization is 
a promising technique that combines advantages 
of both: CABG and PCI. More and more studies 
confirm safety and effectiveness of HCR method 
for complete revascularization in selected patients 
with MVCAD. There are few studies analyzing the 
QoL in this group of patients. This study is one of 
the largest prospective reports including HRQoL in 
patients undergoing HCR in comparison to CABG. 
The present study showed that patients participat-
ing in the POLMIDES study in a 12-month follow 
up achieved a significant improvement in QoL, 
regardless of method of treatment. Improvement 
was measured as an increase in the QoL, and did 
not significantly differ for both groups in each of 
8 domains. The level of education, marital status, 
employment and place of living did not influence 
the improvement of QoL in either group. When 
comparing the QoL scores, both revascularization 
strategies were equally effective. According to 
Bachinsky et al. [19], who compared same-setting 
robotic-assisted hybrid coronary revascularization 
to off-pump coronary artery bypass, QoL at 30 days 
measured using SF-12 questionnaire was better in 
the hybrid group (physical QoL score 32.8 ± 10.4 
vs. 41.6 ± 10.3, p = 0.009). De Cannie’re et al. [20] 
performed a retrospective comparison of 20 pa-
tients with double-vessel CAD treated with staged 
hybrid revascularization with a matched-group of 
patients who underwent on-pump CABG. Quality 
of life was significantly better in the MIDCAB 
group at 6 weeks, whereas the 2-year subsequent 
questionnaire showed no significant difference in 
QoL between the groups. This short-term follow-
up can be a result of an open chest technique or 
adverse reactions often caused by extracorporeal 
circulation during CABG. Previous studies suggest 
that patients undergoing MIDCAB procedures ex-
perience no advantage with regard to postoperative 
pain compared to conventional CABG. A similar ob-
servation was made in POLMIDES study at 1 year 
and observed no significant differences in HRQoL 
between the two modes of revascularization. Fi-
nally, although CABG remains the gold standard, 
HCR offers the same effective method of revascu-
larization, with similar QoL. However, their use is 
restricted to a very limited group of patients. As the 
population of the patients with MVCAD referred 
for CABG are getting older with greater comorbidi-
ties, a less invasive technique should be explored. 
No less important is QoL after these alternative 
procedures. Despite an initially more demanding 
procedure, CABG patients achieved equal level of 
HRQoL when compared with HCR patients.
Limitations of the study
This study had several limitations. First, the 
influence of coexisting depressive disorders on 
QoL, as QoL was not taken into consideration 
and was also influenced by perioperative anxiety 
and depression. Despite these factors, the study 
population is currently the largest published cohort 
of patients comparing these two methods of revas-
cularization and it also reported on QoL. Second, 
some patients completed the questionnaire after 
knowing their randomization group. It seems pos-
sible that the emotional aspect may play a role in 
perioperative period.
Conclusions
Patients with MVCAD after both modes of 
revascularization (CABG and HCR) showed sig-
nificant improvements in QoL from baseline to 
1-year follow-up in all domains. According to the 
literature SF-36 v.2 is one of the most appropriate 
generic instruments to assess HRQoL in patients 
with ischemic heart disease.
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